Drug Approval

FDA FDA Approval FDA Regulations FDA Approvals Regulatory Affairs Anvisa NHS Treatments Semaglutide EMA Eli Lilly

FDA Clears Pancreatic Drug That Shows Early Promise in RAS‑Mutant Lung Cancer

The drug’s cyclophilin A 'molecular glue' mechanism targets a broad set of RAS mutations, with an ongoing Phase 3 trial set to decide a lung‑cancer approval.

5 ARTICLES

last mo.

FDA Grants Accelerated Approval for RP1 (Tudriqev) With Nivolumab in Advanced Melanoma

4 ARTICLES

2mo ago

Autism Leucovorin Prescriptions Jump 2,000% After Media and White House Promotion

4 ARTICLES

4mo ago

FDA Grants Accelerated Approval to First BCL2 Drug for Relapsed Mantle Cell Lymphoma

9 ARTICLES

4mo ago

Lilly Launches First Amyloid-Targeting Alzheimer’s Drug in India at Rs 91,688 a Dose

3 ARTICLES

4mo ago

FDA Approves Bizengri for NRG1 Fusion Cholangiocarcinoma Under Accelerated Pathway

5 ARTICLES

5mo ago

FDA Expands Tzield Use to Delay Type 1 Diabetes in Children Ages 1 to 7

5 ARTICLES

5mo ago

Anvisa Approves Mounjaro for Type 2 Diabetes in Children Ages 10–17

4 ARTICLES

5mo ago

NICE Recommends Zanidatamab for NHS Use in HER2-Positive Biliary Tract Cancer

4 ARTICLES

6mo ago

FDA Grants Accelerated Approval to Lilly’s Oral Weight-Loss Pill Foundayo

7 ARTICLES

6mo ago

FDA Approves Awiqli, First Once-Weekly Basal Insulin for Type 2 Diabetes

9 ARTICLES

6mo ago

FDA Approves First Glucocorticoid Receptor Blocker for Platinum-Resistant Ovarian Cancer

3 ARTICLES

6mo ago

FDA Approves Nivolumab Plus AVD as First-Line Therapy for Advanced Hodgkin Lymphoma

Drug Approval

FDA Clears Pancreatic Drug That Shows Early Promise in RAS‑Mutant Lung Cancer

FDA Grants Accelerated Approval for RP1 (Tudriqev) With Nivolumab in Advanced Melanoma

FDA Approves Lipfendra, First Oral PCSK9 Pill for High LDL Cholesterol

FDA Approves First Oral PCSK9 Pill, Merck’s Lipfendra

FDA Approves Lipfendra, First Oral PCSK9 Pill to Lower LDL

FDA Approves First Oral PCSK9 Pill, Merck’s Lipfendra

FDA Approves Utebzi as First Oral Carbapenem for Complicated UTIs

NHS Approves First New Ovarian Cancer Drug in 20 Years

FDA Expands Afrezza Inhaled Insulin Approval to Children Ages 6 and Up

Autism Leucovorin Prescriptions Jump 2,000% After Media and White House Promotion

Never miss stories about

Drug Approval

FDA Grants Accelerated Approval to First BCL2 Drug for Relapsed Mantle Cell Lymphoma

Lilly Launches First Amyloid-Targeting Alzheimer’s Drug in India at Rs 91,688 a Dose

FDA Approves Bizengri for NRG1 Fusion Cholangiocarcinoma Under Accelerated Pathway

FDA Expands Tzield Use to Delay Type 1 Diabetes in Children Ages 1 to 7

Anvisa Approves Mounjaro for Type 2 Diabetes in Children Ages 10–17

NICE Recommends Zanidatamab for NHS Use in HER2-Positive Biliary Tract Cancer

FDA Grants Accelerated Approval to Lilly’s Oral Weight-Loss Pill Foundayo

FDA Approves Awiqli, First Once-Weekly Basal Insulin for Type 2 Diabetes

FDA Approves First Glucocorticoid Receptor Blocker for Platinum-Resistant Ovarian Cancer

FDA Approves Nivolumab Plus AVD as First-Line Therapy for Advanced Hodgkin Lymphoma

Never miss stories about

Drug Approval